On September 12, 2024, Kimberly Bambach tendered her resignation from her role as interim Chief Financial Officer of the Company, effective October 1, 2024.
Appointed
(interim)
Lisa Wolf
interim Chief Financial Officer and Principal Financial and Principal Accounting Officer
Effective October 1, 2024, Lisa Wolf has been appointed as the Company’s new interim Chief Financial Officer and Principal Financial and Principal Accounting Officer.
Appointed
(interim)
Brian Chesnut
interim Chief Financial Officer
DZS INC.
Effective
2024-09-11
Filed
September 13, 2024, 7:59 PM ET
The Board of Directors (the “Board”) of DZS Inc. (the “Company”) elected Brian Chesnut to serve as the Company’s interim Chief Financial Officer.
Departed
Misty Kawecki
Chief Financial Officer
DZS INC.
Effective
2024-09-11
Successor
Brian Chesnut
Filed
September 13, 2024, 7:59 PM ET
The Board removed Misty Kawecki as the Company’s Chief Financial Officer at such time.
Role change
Jeffrey D. Creech
Executive Vice President and Chief Financial Officer and Principal Accounting Officer
Effective September 9, 2024, Jeffrey D. Creech, our current Executive Vice President and Chief Financial Officer, assumed the role of principal accounting officer.
On September 12, 2024, the Board of Directors (the “Board”) of the Company approved the appointment of Alexander Epshinsky as the Chief Financial Officer of the Company as of September 12, 2024, succeeding Ms. Brown.
Departed
Ryan Maarschalk
Chief Financial Officer
Allied Corp.
Effective
2024-08-19
Filed
September 13, 2024, 7:59 PM ET
On August 21, 2024, effective August 19, 2024, the Company and Ryan Maarschalk entered into a Termination Agreement pursuant to which Mr. Maarschalk ceased to be Chief Financial Officer of the Company.
appointed Neil Barua, the Company’s existing Chief Executive Officer, to the dual positions of President and Chief Executive Officer of the Company effective as of October 1, 2024.
On September 11, 2024, the Board of Directors of PetMed Express, Inc. (“Company”) appointed Robyn D’Elia to serve as the Company’s Chief Financial Officer and to assume the duties of principal financial officer effective September 16, 2024 (“Effective Date”).
terminated Alan H. Shaw, President and Chief Executive Officer of the Company, in connection with preliminary findings from an ongoing investigation conducted by independent counsel that determined Shaw violated Company policies by engaging in a consensual relationship with the Company’s Chief Legal Officer.
Mark R. George, the current Executive Vice President and Chief Financial Officer of the Company, has been appointed as President and Chief Executive Officer of the Company, as a member of the Board and as a member of the Executive Committee of the Board, effective immediately.
Jason A. Zampi, the current Senior Vice President Finance & Treasurer, is being appointed as the Acting Chief Financial Officer of the Company, effective immediately.
Departed
Olivier Thirot
Executive Vice President and Chief Financial Officer
On September 12, 2024, Kelly Services, Inc. (the “Company”) announced that Troy R. Anderson has been named Executive Vice President and Chief Financial Officer designate, with a target start date of October 14, 2024.
Departed
Nathan Hardy
Executive Vice President and Chief Financial Officer
On September 6, 2024, Nathan Hardy notified Sana Biotechnology, Inc. (the “Company”) that he intends to resign from his position as Executive Vice President and Chief Financial Officer of the Company effective October 4, 2024.
Pursuant to the Settlement Agreement, Mr. Khurshid advised the Company that he was resigning as Chief Executive Officer and as a director of the Company effective September 4, 2024.
On September 10, 2024, Mr. Ozan Pamir, the Chief Financial Officer (Principal Financial/Accounting Officer) and Secretary of 180 Life Sciences Corp. (the “Company ", “we” and “us”), tendered his resignation to the board of directors of the Company (the “Board”), effective September 30, 2024.
On September 11, 2024, the Board resolved to appoint Mr. Omar Jimenez, a current member of the Board, as Chief Financial Officer (Principal Financial/Accounting Officer) and Secretary, to fill the vacancy left by Mr. Pamir’s departure, effective on September 30, 2024.
On September 8, 2024, the Board of Directors (the “Board”) of Serina Therapeutics, Inc. (the “Company”) appointed Steven Ledger, the current Interim Chief Executive Officer of the Company, to be the Company’s Chief Executive Officer.
On and effective September 11, 2024, the Board of Directors (the “Board”) of Tilly’s, Inc. (the “Company”) appointed Hezy Shaked, the Company’s co-founder and Executive Chairman of the Board, as the Company’s President and Chief Executive Officer.
the Board of Directors (the “Board”) of Open Lending Corporation (the “Company”) announced that it has appointed Charles D. Jehl as the Chief Executive Officer of the Company on a permanent, non-interim basis and elected Mr. Jehl as a member of the Board, each effective as of the same date.
On September 5, 2024, the Board of Directors (the “Board”) of SentinelOne, Inc. (the “Company”) appointed Barbara Larson as the Company’s Chief Financial Officer and principal financial officer, effective as of September 11, 2024.
As previously announced by the Company on March 7, 2024, the Company’s current Chief Financial Officer, John F. Macke, intends to retire. Mr. Macke’s last day with the Company will be September 27, 2024.
The Board of Directors (“Board”) of Merchants Bancorp (the “Company”) has appointed Sean Sievers as the Company’s Chief Financial Officer effective September 9, 2024.
Effective September 9, 2024, the Board of Directors of Blue Dolphin Energy Company (“Blue Dolphin”) appointed Bryce D. Klug, 44, as principal financial and accounting officer, Treasurer, and Assistant Secretary of Blue Dolphin.
Appointed
Ryan Perfit
Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer
On September 9, 2024, Fluent, Inc. (the “Company”) appointed Ryan Perfit to serve as the Company’s Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer effective as of September 1, 2024.
On September 9, 2024, and effective on September 9, 2024, the Board of Directors appointed Weiting ‘Cathy’ Feng, the Company’s Chief Operating Officer and director, as Chief Financial Officer (Principal Accounting/Financial Officer) of the Company, to fill the vacancy left by Mr. Jimenez’s departure.
Departed
Omar Jimenez
Chief Financial Officer (Principal Financial/Accounting Officer) and Chief Compliance Officer
Effective on September 9, 2024, Mr. Omar Jimenez and Golden Matrix Group, Inc. (the “ Company ”, “ we ” and “ us ”) agreed to mutually terminate the services of Mr. Jimenez as Chief Financial Officer (Principal Financial/Accounting Officer) and Chief Compliance Officer of the Company, effective the same date
Effective September 9, 2024, the Board of Directors (the “Board”) of KalVista Pharmaceuticals, Inc. (the “Company”) appointed Brian Piekos as the Company’s Chief Financial Officer, principal financial officer and principal accounting officer.
In connection with Mr. Anderson’s resignation, Christine Kline, the Vice President and Chief Accounting Officer of the Company, will be named Interim Chief Financial Officer and will assume the duties as the principal financial officer for the Company, effective as of the Effective Date.
Departed
Troy Anderson
Executive Vice President and Chief Financial Officer
On September 5, 2024, Troy Anderson, the Executive Vice President and Chief Financial Officer of Universal Technical Institute, Inc., a Delaware corporation (the “ Company ”), notified the Company that he is resigning from all offices and positions that he holds with the Company and its subsidiaries, effective as of October 11, 2024 (the “ Effective Date ”), to pursue a new position outside the Company.
On September 4, 2024, Anand Kumar, the Interim Chief Executive Officer (“CEO”) of the Company, resigned from his role as CEO, effective immediately to pursue other professional opportunities.
The Company also announced that Nicole Van Denabeele, the Company’s EVP, Chief Accounting Officer has been appointed as the Company’s EVP, Chief Financial Officer and will serve as the Company’s principal financial officer.
On and effective on September 5, 2024, GlobalTech Corporation (the “Company”) appointed Mr. Muhammad Azhar Saeed, the Chief Executive Officer and Director of Worldcall Services (Private) Limited, the Company’s wholly-owned subsidiary, as the Company’s Chief Financial Officer (Principal Financial/Accounting Officer).
In connection with the appointment, effective September 5, 2024, Dana Green, the Chief Executive Officer, President and director of the Company stepped down as Principal Financial/Accounting Officer of the Company.
Mr. Murphy, a named executive officer, will resign as the Company’s Chief Executive Officer and as Chairman of the Company’s Board of Directors (the “Board”) effective September 15, 2024
Appointed
Jason O'Byrne
Executive Vice President and Chief Financial Officer
the Company announced that Jason O’Byrne, MBA, has been appointed as Executive Vice President and Chief Financial Officer and “principal financial officer” of the Company, effective as of October 2, 2024
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.